Krebs Biochemicals rights issue opens today

| Updated on February 26, 2019 Published on February 27, 2019

The ₹25-crore rights issue of Krebs Biochemicals & Industries will open for subscription on Wednesday and end on March 15. The company is offering 21 shares for every 100 held to its existing shareholders at ₹75 share. Krebs Biochemicals had set February 1 as the record date to identify eligible shareholders for the rights issue. The stock will remain in focus, as it closed at ₹87 on the NSE. At the end of December 2018, 4,706 small retail invesotrs hold 11.31 per cent stake.

Published on February 27, 2019
This article is closed for comments.
Please Email the Editor